Member
1 Award

Memsel


Memsel is a biotechnology research and development company dedicated to enhancing health and combatting infections through advanced phage therapies and targeted delivery systems. The company aims to transform healthcare solutions across human, animal, and plant domains, addressing critical health challenges and antibiotic resistance.

Industries

N/A

Nr. of Employees

small (1-50)

Memsel

3500 Camp Bowie Blvd. EAD-116, Fort Worth TX 76107

Awards

Fiscal Year 2025 Multi-Topic Request for Project Proposals

Advanced Wound Care Solutions for Multi-Drug Resistant Infections and Hemorrhage Control in Battlefield Conditions

Funding (ceiling)

$4,779,586.3

Award Year

2025


Products

Sprayable and injectable multicomponent wound-care system

A multicomponent wound-care formulation delivered as sprayable or injectable hydrogel that combines hemostatic action, infection control (phage cocktails, antibiotics, antifungals), analgesic release, and tissue-repair support for trauma and prolonged field care.

Enteric microsphere system for GI-targeted delivery (triple-action formulation)

An enteric-coated microsphere platform for oral delivery that protects bioactives through the stomach and provides controlled release in the small and large intestine; used to combine phage therapies, probiotics, and short-chain fatty acids in a single oral formulation.

Expertise Areas

  • Phage therapy development
  • Targeted drug delivery
  • Wound care therapeutics and hemostasis
  • Gut microbiome therapeutics and enteric delivery
  • Show More (5)

Key Technologies

  • Bacteriophage isolation and characterization
  • High-throughput screening
  • Phage engineering and induction
  • Phage cocktail formulation
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.